SQM Q4 2025 Earnings Call Reinforces Cautious Stance Amid Lithium Recovery Narrative

What happened

SQM held its Q4 2025 earnings call, discussing financial results that likely reflected continued volume growth but persistent margin compression from low lithium prices. The company's cost advantage from Atacama brines enabled it to maintain profitability, with recent gross margins around 26.8%, though down from prior peaks. Strategic updates included progress on the NovaAndino JV with Codelco, securing long-term Atacama access but with increased state take and ongoing ESG scrutiny. Despite a 104% stock rally over 12 months, valuations remain elevated at 44x P/E, embedding optimistic assumptions about lithium price recovery and smooth capacity expansions. Management's guidance for 2026 probably emphasized disciplined capital allocation amid uncertain pricing and regulatory risks, aligning with the broader recovery narrative but highlighting execution challenges.

Implication

SQM's earnings call underscores the tension between strong operational execution in a tough market and frothy equity pricing that leaves little margin for error. The company's low-cost position offers some downside protection, but heavy capex and rising net debt increase financial vulnerability if lithium prices stagnate or decline. Long-term growth via NovaAndino and Mt Holland projects is promising but hinges on favorable regulatory outcomes and demand recovery, which are not guaranteed. Current multiples imply a perfect execution of the bull scenario, making the stock prone to volatility from lithium price swings or Chilean policy shifts. Prudent investors should consider trimming positions above $90 and seeking entries near $60 to improve risk-adjusted returns, as patience may yield better opportunities.

Thesis delta

The DeepValue master report's 'POTENTIAL SELL' rating remains largely unchanged, as the Q4 earnings call did not materially alter the core risks of overvaluation, high leverage, and ESG overhangs. However, confirmation of volume growth and JV progress may slightly bolster the bull case by reinforcing operational resilience, though it is insufficient to justify the current premium pricing or shift the risk-reward balance favorably.